| Value | ₹600.0 Cr |
|---|---|
| Execution period | Two phases: by 30 Sep 2028 (Phase I) and by 30 Sep 2030 (Phase II) |
| aluminium foil production capacity | 12000 MTPA |
NSE filing, NSE: SRF. Summary written from the filing by ALFA Finder's alert engine.
SRF Ltd: key numbers
- Share price
- ₹2,335.50
- Market cap
- ₹69,230 Cr
- Revenue (annual)
- ₹15,787 Cr
- Net profit (annual)
- ₹1,835 Cr
- P/E (TTM)
- 30.3×Sector 34.1×
- Promoter holding
- 50.26%+0.00% QoQ
- FII holding
- 15.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SRF Ltd
All →SRF Earnings Call Transcript: Key Takeaways
SRF delivered robust revenue growth driven by chemical segment recovery and packaging films stability. Management remains optimistic about H2 FY27 performance despite global geopolitical and logistics headwinds.
- Call
- Guides 20% growth
SRF Investor Presentation: Key Takeaways
SRF reported strong Q2FY27 performance with revenue at ₹4,904.2 Cr, driven by high growth in Chemicals and Performance Films. Strategic shift continues toward high-value battery foil and sunrise sectors.
SRF Results Update
SRF Ltd reported Q2 FY27 revenue ₹4,904 Cr (+35% YoY) and PAT ₹509 Cr. Board approved ₹600 Cr for a 12,000 MTA aluminium foil plant.
- battery-grade aluminium foil manufacturing capacity
- 12000 MTA
SRF Q2 FY27 Results: Net Profit ₹509.1 Cr, Up 31.1% YoY
SRF Ltd reported revenue from operations of ₹4,904 Cr (+34.7% YoY) and net profit of ₹509.1 Cr (+31.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹509.1 Cr · +31.1% YoY
SRF Other Announcement
SRF Limited submitted its quarterly Shareholding Pattern for the period ending September 30, 2026, as required under SEBI Regulation 31.
SRF Board Meeting Date
SRF Limited will hold a Board of Directors meeting on October 21, 2026, to consider and approve the company's unaudited financial results for the quarter ending September 2026.
Other capacity expansion announcements
All →Lotus Eye Hospital and Institute Capacity Expansion
Lotus Eye Hospital opened its 11th branch at Erode, Tamil Nadu, commencing operations on October 30, 2026. The branch was inaugurated with state government ministers and local MLAs in attendance.
- new branches
- 1.0 branches
Infosys Capacity Expansion
Infosys inaugurated a new 1.1 million sq ft Software Development Block at its Pocharam campus in Hyderabad. The block adds 10,000 seats, supporting over 13,000 additional employees under a hybrid model.
- new development block seats
- 10000 seats
Avenue Supermarts Capacity Expansion
Avenue Supermarts opened a new store at GHS Mall, Pune today, taking its total store count to 519. This is a routine operational expansion with no monetary value disclosed.
- new stores
- 1.0 stores
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Shekhawati Industries Capacity Expansion
Shekhawati Industries entered a development agreement for a residential and commercial project at Mudre Khurd, Karjat. The project covers about 2,00,000 sq. ft. with around 200 apartments, marking its entry into real estate.
- development area
- 200000 sq. ft.
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds